Company / PP&E (Net)
CG Oncology, Inc. PP&E (Net) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$15.6M
FY2025
5-year range
$69.0K / $15.6M
FY2023-FY2025
Trend
+5633.8%
vs FY2024
Sector context
#86 of 195
Health Care
What the data says
PP&E (Net) changed +5634% YoY in FY2025, a notable deviation from the 2-year average annual change of +2964%.
Based on SEC 10-K filings.
$16M in FY2025.
Improved from $69,000 to $16M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#86 of 195 in Health CareTop 44% of 195This company $15.6M Sector average $771.3M
▼
-98.0% below sector average
Key checks
Key Insights
- In FY2025, pp&e (net) increased 5633.8% year-over-year.
- Ranks #86 out of 195 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 8.02 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.6M | +5633.8% |
| FY2024 | $272.0K | +294.2% |
| FY2023 | $69.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026